Uncontrolled diabetes may result in hearing loss in women, much like it affects vision or kidney function, according to the results of a new study.
Uncontrolled diabetes may result in hearing loss in women, much like it affects vision or kidney function, according to the results of a new study.
“There have been studies that demonstrate that hearing loss is greater in diabetics than normal individuals,” study investigator Kathleen L. Yaremchuk, MD, Chair, Department of Otolaryngology-Head and Neck Surgery, Henry Ford Hospital, Detroit, told Formulary. “This is the first study that demonstrates that the control of the diabetes can impact the degree of hearing loss that occurs in diabetics.”
The study was presented January 26 at the annual Triological Society's Combined Sections Meeting in Miami Beach, Fla.
The investigators conducted a retrospective chart review of 990 patients who had audiograms performed between 2000 and 2008. Patients were classified by gender, age, and diabetic control (as determined by the American Diabetes Association guidelines that use HbA1C blood levels).
A 3-way analysis of variance was used to examine pure tone average (PTA), speech-frequency PTA, high-frequency PTA, and word recognition scoring (WRS).
The investigators found that there was a statistically significant difference in average PTA for women aged 60 to 75 and those younger than 60 with well-controlled diabetes and poorly controlled diabetes compared with those who did not have diabetes. Among women younger than 60, those with diabetes had worse hearing than non-diabetic women, regardless of whether it was controlled.
A breakdown of the research:
Well-controlled diabetes (<60 years, PTA, 20.0; 60 to 75 years, PTA, 27.0)
Poorly controlled diabetes (<60 years, PTA, 22.1; 60 to 75 years, PTA, 29.6)
No diabetes (<60 years, PTA, 14.8; 60 to 75 years, PTA, 23.6)
The investigators saw no similar correlations among men, who had greater hearings loss than women in all age groups. Men are more likely to be exposed to noise through work, hobbies, and social activities, Dr Yaremchuk said.
“We have known for some time that the control of diabetes was related to kidney function, peripheral neuropathy, and diabetic retinopathy. This study now demonstrates the same is true for hearing,” she said. “Future research would be a prospective, long-term study looking at noise exposure and diabetes status in a population.”
Coalition promotes important acetaminophen dosing reminders
November 18th 2014It may come as a surprise that each year Americans catch approximately 1 billion colds, and the Centers for Disease Control and Prevention estimates that as many as 20% get the flu. This cold and flu season, 7 in 10 patients will reach for an over-the-counter (OTC) medicine to treat their coughs, stuffy noses, and sniffles. It’s an important time of the year to remind patients to double check their medicine labels so they don’t double up on medicines containing acetaminophen.
Support consumer access to specialty medications through value-based insurance design
June 30th 2014The driving force behind consumer cost-sharing provisions for specialty medications is the acquisition cost and not clinical value. This appears to be true for almost all public and private health plans, says a new report from researchers at the University of Michigan Center for Value-Based Insurance Design (V-BID Center) and the National Pharmaceutical Council (NPC).
Management of antipsychotic medication polypharmacy
June 13th 2013Within our healthcare-driven society, the increase in the identification and diagnosis of mental illnesses has led to a proportional increase in the prescribing of psychotropic medications. The prevalence of mental illnesses and subsequent treatment approaches may employ monotherapy as first-line treatment, but in many cases the use of combination of therapy can occur, leading to polypharmacy.1 Polypharmacy can be defined in several ways but it generally recognized as the use of multiple medications by one patient and the most common definition is the concurrent use of five more medications. The presence of polyharmacy has the potential to contribute to non-compliance, drug-drug interactions, medication errors, adverse events, or poor quality of life.
Medical innovation improves outcomes
June 12th 2013I have been diagnosed with stage 4 cancer of the pancreas, a disease that’s long been considered not just incurable, but almost impossible to treat-a recalcitrant disease that some practitioners feel has given oncology a bad name. I was told my life would be measured in weeks.